Fig. 4

P-cadherin scores in primary, metastatic, and recurrent lesions were analyzed. a: P-cadherin score of primary tumor and peritoneal dissemination were compared (n = 49, P = .89). b: P-cadherin score of primary tumor and metastatic lymph nodes were compared (n = 14, *P = .0079). c: P-cadherin score of primary and recurrent tumors were compared (n = 8, P = .202). *P < 0 .01, NS: not significant